These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15710917)

  • 1. Ovarian cancer screening.
    Allen DM
    CMAJ; 2005 Feb; 172(4):447. PubMed ID: 15710917
    [No Abstract]   [Full Text] [Related]  

  • 2. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].
    Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK
    Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer screening: are we making any progress?
    Paley PJ
    Curr Opin Oncol; 2001 Sep; 13(5):399-402. PubMed ID: 11555720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic markers for ovarian cancer screening: not ready for routine clinical use.
    Coates RJ; Kolor K; Stewart SL; Richardson LC
    Clin Cancer Res; 2008 Nov; 14(22):7575-6; author reply 7577-9. PubMed ID: 18948387
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of test positive predictive value in ovarian cancer screening.
    Greene MH; Feng Z; Gail MH
    Clin Cancer Res; 2008 Nov; 14(22):7574; author reply 7577-9. PubMed ID: 18948386
    [No Abstract]   [Full Text] [Related]  

  • 6. [Difficulties and future of mass screening of cancer of the uterine body and ovary].
    Kato S; Yakushihi M
    Gan No Rinsho; 1970; 16(3):191-6. PubMed ID: 5463011
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Lessons from controversy: Ovarian cancer screening and serum proteomics.
    Xu R; Gamst A
    J Natl Cancer Inst; 2005 Aug; 97(16):1226; author reply 1227. PubMed ID: 16106029
    [No Abstract]   [Full Text] [Related]  

  • 8. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
    Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer screening.
    Eason EL
    CMAJ; 2005 Feb; 172(4):447. PubMed ID: 15710918
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of early diagnosis in managing ovarian cancer.
    Dunleavey R
    Nurs Times; 2006 Oct 10-16; 102(41):28-9. PubMed ID: 17059048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prophylactic oophorectomy. An unsolved problem].
    Salvatores M; Mage G; Wattiez A
    Minerva Ginecol; 2007 Oct; 59(5):549-52. PubMed ID: 17912181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer symptom index: possibilities for earlier detection.
    Black SS; Butler SL; Goldman PA; Scroggins MJ
    Cancer; 2007 Jan; 109(2):167-9. PubMed ID: 17154391
    [No Abstract]   [Full Text] [Related]  

  • 13. Ovarian cancer screening.
    Kyrgiou M; Tsoumpou I; Martin-Hirsch P; Arbyn M; Prendiville W; Koliopoulos G; Dalkalitsis N; Stamatopoulos P; Paraskevaidis E
    Anticancer Res; 2006; 26(6C):4793-801. PubMed ID: 17214343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of cancer screening.
    Collins LG; Wynn DT; Barash JH
    Prim Care; 2009 Sep; 36(3):623-39. PubMed ID: 19616158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trouble with ovarian cancer.
    Lancet; 2009 Oct; 374(9698):1302. PubMed ID: 19837234
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies for ovarian cancer prevention.
    Dann RB; Kelley JL; Zorn KK
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):667-86, viii. PubMed ID: 18061863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why ovarian cancer awareness?
    Cross LL
    Okla Nurse; 2005; 50(1):12. PubMed ID: 15786860
    [No Abstract]   [Full Text] [Related]  

  • 18. Proteins' promise--progress and challenges in ovarian cancer proteomics.
    Koehn H; Oehler MK
    Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovarian cancer--trends].
    Dargent D
    Contracept Fertil Sex; 1995 Feb; 23(2):122-6. PubMed ID: 7894543
    [No Abstract]   [Full Text] [Related]  

  • 20. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.